MedTrace Logo

The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

NCT04205201 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-12-26

No results posted yet for this study

Summary

Outpatient department of cmch, ceitc,cimch POAG patients enrolled for the study.

Conditions

  • To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients

Interventions

DRUG

Drugs, Investigational

To see the safety and efficacy of topical latanoprost compared with topical brimonidine in the treatment of the primary open angle

Sponsors & Collaborators

  • Chittagong Medical College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-25
Primary Completion
2019-09-24
Completion
2019-10-05

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04205201 on ClinicalTrials.gov